Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

702
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
702
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

461
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
461
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

292
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
292

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebrovascular Diagnoses During First Recorded Pregnancies in a 17-Year Period-A Nationwide Analysis of Healthcare Administrative Records Between 2004 and 2020 in a Central-Eastern European Population.

Epidemiologia (Basel, Switzerland)·2026
Same author

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Journal of neurology·2026
Same author

Asundexian for Secondary Stroke Prevention.

The New England journal of medicine·2026
Same author

Concomitant Dysregulation of Cerebral Vasoreactivity and Arterial Blood Pressure Is Closely Related in Patients with Carotid Stenosis.

Life (Basel, Switzerland)·2026
Same author

[Paradigm shift in multiple sclerosis patient care at the Center of Neuro-immunology, Semmelweis University - data of 17 years].

Ideggyogyaszati szemle·2026
Same author

[Awards of Hungarian neurology and their awardees: 1936-2025].

Ideggyogyaszati szemle·2026

Related Experiment Video

Updated: Dec 25, 2025

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
06:28

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation

Published on: December 13, 2024

1.0K

[Serum biomarkers in acute low back pain and sciatica].

Kitti Dénes1, Zsuzsanna Arányi1, Anita Csillik1

  • 1Általános Orvostudományi Kar, Neurológiai Klinika,Semmelweis EgyetemBudapest, Balassa u. 6., 1083.

Orvosi Hetilap
|March 24, 2020
PubMed
Summary

Inflammation plays a key role in acute low back pain and sciatica. Identifying specific inflammatory biomarkers may help personalize treatment for better outcomes.

Keywords:
biomarkerekbiomarkerscitokinekcytokinesderékfájdalomgyulladásinflammationlow back painlumboischialgiasciatica

More Related Videos

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
04:42

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation

Published on: June 26, 2018

15.0K
Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain
05:10

Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain

Published on: August 30, 2022

3.3K

Related Experiment Videos

Last Updated: Dec 25, 2025

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
06:28

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation

Published on: December 13, 2024

1.0K
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
04:42

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation

Published on: June 26, 2018

15.0K
Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain
05:10

Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain

Published on: August 30, 2022

3.3K

Area of Science:

  • Biomedical science
  • Immunology
  • Pain medicine

Background:

  • Inflammation is a key factor in low back pain and sciatica.
  • Research has primarily focused on chronic pain, with less attention to acute phases.
  • Elevated inflammatory biomarkers are increasingly linked to these conditions.

Purpose of the Study:

  • To explore the role of inflammatory biomarkers in acute low back pain and sciatica.
  • To identify patient subgroups based on biomarker levels for personalized medicine.
  • To assess the potential for anti-inflammatory treatments in specific patient groups.

Main Methods:

  • Review of existing research on cytokines (e.g., TNF-α, IL-6, IL-8, IL-4, IL-10) and their association with low back pain and sciatica.
  • Analysis of studies focusing on both acute and chronic pain phases.
  • Consideration of personalized medicine approaches based on inflammatory profiles.

Main Results:

  • Pro-inflammatory cytokines (TNF-α, IL-6, IL-8) and anti-inflammatory cytokines (IL-4, IL-10) are implicated in intervertebral disc herniation.
  • Identifying patients with inflammation as the primary pain driver could enable targeted anti-inflammatory therapy.
  • Existing trials show potential for TNF-α and IL-6 inhibitors, but more research is needed.

Conclusions:

  • Circulating biomarkers can aid in the personalized diagnosis and treatment of acute low back pain and sciatica.
  • Further research is required to fully understand the role of inflammation and identify prognostic biomarkers.
  • Clinical practice needs validated methods for evaluating inflammation in acute low back pain and sciatica.